Anthropic，将成为全球最大AI医疗公司！CEO预言：未来10年，AI将治愈大多数疾病

TL;DR - Anthropic is expanding aggressively into life sciences and healthcare, while CEO Dario Amodei predicts AI could help cure most diseases within 5–10 years. The push spans Claude-based research tools, pharmaceutical partnerships, acquisitions, scientific hiring, and potential in-house drug development, though medical experts dispute the timeline.

• Anthropic launched Claude for Life Sciences and Claude Science to support research workflows, knowledge/tool integration, regulatory drafting, and clinical-trial planning.
• The company has partnered with pharmaceutical firms and research institutions and is extending Claude to tasks for clinicians, insurers, and healthcare organizations.
• Anthropic reportedly acquired AI-drug-discovery startup Coefficient Bio, recruited AlphaFold researcher John Jumper, and is building an internal biology team and rare-disease pipeline.
• Critics argue that lengthy clinical trials and biological complexity make Amodei’s proposed 5–10-year timeline unrealistic and potentially misleading to patients.